Skip to content
Independent and accessible public media is needed more than ever.
Help us continue keeping communities informed and inspired.
Keep public media independent and accessible
Donate Now

View thank you gift options

CapRadio

CapRadio

signal status listen live donate
listen live donate signal status
listen live donate signal status
  • News
    • topics
    • State Government
    • Environment
    • Health Care
    • Race and Equity
    • Business
    • Arts and Lifestyle
    • Food and Sustainability
    • PolitiFact California
  • Music
    • genres
    • Classical
    • Jazz
    • Eclectic
    • Daily Playlist
  • Programs + Podcasts
    • news
    • Morning Edition
    • All Things Considered
    • Marketplace
    • Insight With Vicki Gonzalez
    • music
    • Acid Jazz
    • At the Opera
    • Classical Music
    • Connections
    • Excellence in Jazz
    • Hey, Listen!
    • K-ZAP on CapRadio
    • Mick Martin's Blues Party
    • Programs A-Z
    • Podcast Directory
  • Schedules
    • News
    • Music
    • ClassicalStream
    • JazzStream
    • Weekly Schedule
    • Daily Playlist
  • Community
    • Events Calendar
    • CapRadio Garden
    • CapRadio Reads
    • Ticket Giveaways
  • Support
    • Evergreen Gift
    • One-Time Gift
    • Corporate Support
    • Vehicle Donation
    • Stock Gift
    • Legacy Gift
    • Endowment Gift
    • Benefits
    • Member FAQ
    • e‑Newsletter
    • Drawing Winners
    • Thank You Gifts
  • About Us
  • Contact Us
  • Close Menu

FDA authorizes first COVID booster for children ages 5 to 11

Tuesday, May 17, 2022 | Sacramento, CA
Scott Olson/Getty Images

First grader Rihanna Chihuaque, 7, receives a COVID-19 vaccine at Arturo Velasquez Institute in Chicago last November.

Scott Olson/Getty Images

Rob Stein | NPR

The Food and Drug Administration Tuesday authorized the first COVID-19 vaccine booster for children ages 5 to 11.

The authorization makes all children in that age group who received their second shot at least five months ago eligible to receive a third shot of the Pfizer-BioNTech vaccine.

The companies requested the authorization based on a small study that the companies and FDA said demonstrated a third shot is safe and can significantly boost antibody levels, countering waning immunity and providing added protection against the virus, including the more contagious omicron variant.

Until now, only children ages 12 and older and adults were eligible for a booster.

"While it has largely been the case that COVID-19 tends to be less severe in children than adults, the omicron wave has seen more kids getting sick with the disease and being hospitalized, and children may also experience longer term effects, even following initially mild disease," said FDA Commissioner Robert M. Califf in a statement.

"The FDA is authorizing the use of a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age to provide continued protection against COVID-19," Califf said. "Vaccination continues to be the most effective way to prevent COVID-19 and its severe consequences, and it is safe."

It remains unclear how much of a demand there will be for the boosters. Less than a third of children ages 5 to 11 are fully vaccinated, and only about a quarter of adolescents have received a booster.

Many doctors and parents have been hoping for the authorization, saying it's important to provide children with as much protection as possible, especially as the number of people catching the virus is rising again and so few people are now wearing masks.

"Since authorizing the vaccine for children down to 5 years of age in October 2021, emerging data suggest that vaccine effectiveness against COVID-19 wanes after the second dose of the vaccine in all authorized populations," said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, in a statement.

"The FDA has determined that the known and potential benefits of a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for children 5 through 11 years of age at least five months after completing a primary series outweigh its known and potential risks and that a booster dose can help provide continued protection against COVID-19 in this and older age groups," Marks said.

But others are skeptical, saying two shots are still providing strong protection against serious disease and death, and the it remains unclear how much added protection a third shot will provide or how long it will last.

The FDA didn't ask its outside advisers for input on the decision because the agency said the committee had previously discussed the issues and no new questions were raised.

The Centers for Disease Control and Prevention's advisers on vaccine practices will meet Thursday and are expected to discuss implementation of a booster dose for this age group.


Follow us for more stories like this

CapRadio provides a trusted source of news because of you.  As a nonprofit organization, donations from people like you sustain the journalism that allows us to discover stories that are important to our audience. If you believe in what we do and support our mission, please donate today.

Donate Today  

    More about Coronavirus

  • NIAID-RML via AP

    Coronavirus In California: Latest Updates And Resources

    The coronavirus has impacted nearly every aspect of life in California and around the world. Here are resources and all our coverage at CapRadio and NPR.
  • Health Care
  •  

 Coronavirus

Sign up for ReCap and never miss the top stories

Delivered to your inbox every Friday.

 

Check out a sample ReCap newsletter.

Thanks for subscribing!

Thank you for signing up for the ReCap newsletter! We'll send you an email each Friday with the top stories from CapRadio.

Browse all newsletters
 We Get Support From:
Become a Supporter 
 We Get Support From:
Become a Supporter 

Back to Top

  • CapRadio

    7055 Folsom Boulevard
    Sacramento, CA 95826-2625

    • (916) 278-8900
    • Toll-free (877) 480-5900
    • Email Us
    • Submit a News Tip
  • Contact Us

  • About Us

    • Contact Us / Feedback
    • Coverage
    • Directions
    • Careers & Internships
    • Mission / Vision / Core Values
    • Press
    • Staff Directory
    • Board of Directors
  • Listening Options

    • Mobile App
    • On Air Schedules
    • Smart Speakers
    • Playlist
    • Podcasts
    • RSS
  • Connect With Us

    •  Facebook
    •  Twitter
    •  Instagram
    •  YouTube
  • Donate

  • Listen

  • Newsletters

CapRadio stations are licensed to California State University, Sacramento. © 2022, Capital Public Radio. All Rights Reserved. Privacy Policy | Website Feedback FCC Public Files: KXJZ KKTO KUOP KQNC KXPR KXSR KXJS. For assistance accessing our public files, please call 916-278-8900 or email us.